Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4438126

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1nc(-c2nc3cccc(C)c3n2C)c(C)c(-c2ccc(Cl)cc2)c1[C@H](OC(C)(C)C)C(=O)O

Basic Information

ChEMBL ID CHEMBL4438126
Phase Preclinical
Structure Type MOL
InChI Key YWNZJLYNCIZHAA-VWLOTQADSA-N
1
Targets
1
Activities
1
Assay Types
1
PK Parameters
2
Publications
0
Known Names

Molecular Properties

492.0
MW (Da)
6.82
ALogP
5
HBA
1
HBD
77.2
PSA (Ų)
0.33
QED
1
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C28H30ClN3O3
MW 492.02
Aromatic Rings 4
Heavy Atoms 35
NP-Likeness -0.54

Activity Summary

EC50 1 meas. best 8.52

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
EC50 8.52 8.52 3.0 1

Pharmacokinetic Data

Parameter Value Units Species
T1/2 2.0 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked EC50 = 3.0 nM 8.52 Inhibition of HIV NL4.3 integrase T124/T125 double mutant assessed as reduction ... 27563405

Literature References

PubMed DOI Target Context # Activities
27563405 10.1021/acsmedchemlett.6b00194 Unchecked 2
27563405 10.1021/acsmedchemlett.6b00194 ADMET 1

Data from ChEMBL 36 via Core Engine